Form 4: Compass Pathways Director Sells Shares in Private Transaction

Ekaterina Malievskaia, a director at Compass Pathways, sold 776,565 ordinary shares in a private transaction to Lars Wilde, a former co-founder, on October 24, 2024.

Summary

• Ekaterina Malievskaia, a director at Compass Pathways plc, sold 776,565 ordinary shares on October 24, 2024.
• The sale was a private transaction to Lars Wilde, a former co-founder of Compass Pathways.
• The transaction was executed pursuant to previously disclosed call option agreements dating back to May 19, 2020, and subsequently amended.
• Mr. Wilde exercised his option to purchase the shares for a nominal value per ordinary share.
• Following the transaction, Dr. Malievskaia directly owns 3,152,848 ordinary shares and indirectly owns 3,155,122 ordinary shares through her spouse.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to pre-existing agreements. It doesn't inherently indicate positive or negative sentiment regarding the company's performance or future prospects.

Industry Context

This transaction represents a private agreement between a company director and a former co-founder, and doesn't necessarily reflect broader market trends in the pharmaceutical or psychedelic medicine industry. It is related to pre-existing agreements.

Related Party Transactions

• The sale of shares to Lars Wilde, a former co-founder, constitutes a related party transaction.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant given the pre-existing agreements.

Key Dates